Hydrogenology
Hydrogenology editorial study record

Hydration bioanalyses of the effects of hydrogen-rich water (HRW)

Pesotskaya LA, Ignatov II, Popova TP, Huether F, Ignatov AI. · Wiad Lek. 2026;79(4):690–699.

HumanH₂-rich waterPublished 2026
Study record, not medical adviceThis page reports one source and Hydrogenology’s source-text extraction. It does not establish that molecular hydrogen is effective, safe or appropriate for any person. Human, animal and laboratory evidence must not be treated as equivalent.
Source and classification

What kind of evidence is this?

Evidence stream

Human

Reported design

Uncontrolled before-and-after study

Research topic

Other molecular hydrogen research

Administration classification

H₂-rich water

Study result signal

Exploratory within-person laboratory signal.

Outcome type

Hydration-related laboratory and hemorheological outcomes.

Reported in the source

Methods at a glance

Population or model

Ten healthy adult volunteers.

Sample

10 participants; sex-stratified observations were reported.

Duration

21 days.

Intervention

Regular consumption of Hydrogen Evodrop-rich water for 21 days.

Hydrogen form

H₂ dissolved in drinking water.

H₂ specification

Reported dissolved H₂ concentration 0.9–1.2 ppm; the daily volume was not stated.

H₂ flow

Not applicable — drinking water.

O₂ delivered with H₂

No oxygen was co-delivered.

Comparator

Participants before the intervention; no concurrent control group.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Hematocrit, blood viscosity, urine osmolality and erythrocyte morphology.

Reported result

The article reports changes from baseline in hematocrit, blood-viscosity measures and urine osmolality; it reports no erythrocyte agglutination or morphological abnormality.

Results-extraction completeness

The full article methods, intervention, outcomes, positive and null findings, funding and conflict statements were checked.

A reported association, difference or mechanism is not automatically a clinical benefit. Null findings, outcome type, study design and precision all matter.

Interpretation limits

Cautions and applicability

Design and reporting cautions

Very small uncontrolled study, no clinical endpoint and no reported daily water volume. One author is a co-inventor on a related patent.

Applies directly to

Healthy volunteers under this short protocol only.

Preliminary appraisal framework

ROBINS-I — preliminary

Preliminary risk-of-bias status

Serious concerns

Appraisal rationale

No concurrent comparator, very small sample and multiple laboratory outcomes make the estimates highly vulnerable to confounding, time effects and selective reporting.

Appraisal domains

Selection and allocation checked · Confounding and co-interventions remain possible · Missing observations checked where reported · Outcome measurement varies by endpoint · Selective reporting cannot be excluded

No single-study GRADE certainty rating is assigned. Certainty is assessed by important outcome across a complete eligible evidence set, not by attaching a final grade to one source.

Provenance

Sources and record status

Identifiers

PMID: 42139605 · DOI: 10.36740/wlek/218738

Publisher access

A free publisher or repository full article was checked.

Extraction basis

Publisher or repository full article and bibliographic record; checked 10 August 2026.

Record revision

2026-08-10